文献速递临床试验与 GCP基础与转化研究

静脉输注维生素C对脓毒症合并重度急性呼吸衰竭患者器官衰竭及炎症与血管损伤生物标志物的影响:CITRIS-ALI随机临床试验

Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

CITRIS-ALI为美国7个ICU开展的双盲安慰剂对照多中心随机试验,纳入167例脓毒症合并ARDS病程不足24小时的患者,比较每6小时静脉输注维生素C(50 mg/kg,n=84)与安慰剂(n=83)持续96小时的效果。主要终点为基线至96小时改良SOFA评分变化及168小时炎症与血管损伤生物标志物,两组均无显著差异。

要点

  • 维生素C组与安慰剂组基线至96小时改良SOFA评分变化无显著差异(3分 vs 3.5分,差值-0.10,95%CI -1.23至1.03,P=.86)。
  • 168小时C反应蛋白(54.1 vs 46.1 μg/mL,差值7.94 μg/mL,P=.33)与血栓调节蛋白(14.5 vs 13.8 ng/mL,差值0.69 ng/mL,P=.70)均无显著差异。
  • 作者结论:96小时维生素C输注未显著改善器官功能障碍评分,也未改变炎症与血管损伤标志物。

核心结论

  • 在这项脓毒症合并ARDS患者的初步研究中,与安慰剂相比,96小时维生素C输注未显著改善器官功能障碍评分,也未改变炎症与血管损伤标志物。
  • 需要进一步研究评估维生素C对脓毒症和ARDS其他结局的潜在作用。

研究设计与样本

  • CITRIS-ALI为随机、双盲、安慰剂对照、多中心试验,在美国7个内科重症监护病房开展。
  • 研究于2014年9月至2017年11月进行,最终随访至2018年1月。
  • 纳入脓毒症合并ARDS病程不足24小时的患者167例,随机分为维生素C组84例和安慰剂组83例。
  • 干预为每6小时静脉输注维生素C(50 mg/kg溶于5%葡萄糖水)或安慰剂(仅5%葡萄糖水),持续96小时。

主要发现

  • 167例随机患者平均(SD)年龄54.8岁(16.7),男性90例(54%),103例(62%)完成研究至第60天。
  • 基线至96小时改良SOFA评分变化:维生素C组从9.8降至6.8(3分),安慰剂组从10.3降至6.8(3.5分),差值-0.10(95%CI -1.23至1.03;P=.86)。
  • 168小时C反应蛋白水平:维生素C组54.1 μg/mL vs 安慰剂组46.1 μg/mL,差值7.94 μg/mL(95%CI -8.2至24.11;P=.33)。
  • 168小时血栓调节蛋白水平:维生素C组14.5 ng/mL vs 安慰剂组13.8 ng/mL,差值0.69 ng/mL(95%CI -2.8至4.2;P=.70)。

关键数值与推荐

  • 主要终点为基线至96小时改良SOFA评分变化(范围0-20,评分越高表示功能障碍越重)。
  • 主要终点还包括在0、48、96和168小时测定的血浆炎症标志物(C反应蛋白)和血管损伤标志物(血栓调节蛋白)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文称该研究为初步研究。
  • 需要进一步研究评估维生素C对脓毒症和ARDS其他结局的潜在作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Experimental data suggest that intravenous vitamin C may attenuate inflammation and vascular injury associated with sepsis and acute respiratory distress syndrome (ARDS). OBJECTIVE: To determine the effect of intravenous vitamin C infusion on organ failure scores and biological markers of inflammation and vascular injury in patients with sepsis and ARDS. DESIGN, SETTING, AND PARTICIPANTS: The CITRIS-ALI trial was a randomized, double-blind, placebo-controlled, multicenter trial conducted in 7 medical intensive care units in the United States, enrolling patients (N = 167) with sepsis and ARDS present for less than 24 hours. The study was conducted from September 2014 to November 2017, and final follow-up was January 2018. INTERVENTIONS: Patients were randomly assigned to receive intravenous infusion of vitamin C (50 mg/kg in dextrose 5% in water, n = 84) or placebo (dextrose 5% in water only, n = 83) every 6 hours for 96 hours. MAIN OUTCOMES AND MEASURES: The primary outcomes were change in organ failure as assessed by a modified Sequential Organ Failure Assessment score (range, 0-20, with higher scores indicating more dysfunction) from baseline to 96 hours, and plasma biomarkers of inflammation (C-reactive protein levels) and vascular injury (thrombomodulin levels) measured at 0, 48, 96, and 168 hours. RESULTS: Among 167 randomized patients (mean [SD] age, 54.8 years [16.7]; 90 men [54%]), 103 (62%) completed the study to day 60. There were no significant differences between the vitamin C and placebo groups in the primary end points of change in mean modified Sequential Organ Failure Assessment score from baseline to 96 hours (from 9.8 to 6.8 in the vitamin C group [3 points] and from 10.3 to 6.8 in the placebo group [3.5 points]; difference, -0.10; 95% CI, -1.23 to 1.03; P = .86) or in C-reactive protein levels (54.1 vs 46.1 μg/mL; difference, 7.94 μg/mL; 95% CI, -8.2 to 24.11; P = .33) and thrombomodulin levels (14.5 vs 13.8 ng/mL; difference, 0.69 ng/mL; 95% CI, -2.8 to 4.2; P = .70) at 168 hours. CONCLUSIONS AND RELEVANCE: In this preliminary study of patients with sepsis and ARDS, a 96-hour infusion of vitamin C compared with placebo did not significantly improve organ dysfunction scores or alter markers of inflammation and vascular injury. Further research is needed to evaluate the potential role of vitamin C for other outcomes in sepsis and ARDS. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02106975.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Fowler AA, Truwit JD, Hite RD, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019. PMID: 31573637. doi:10.1001/jama.2019.11825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。